Trial Profile

A phase 2 clinical trial of FOR-6219 for Endometriosis

Status: Withdrawn prior to enrolment

Phase of Trial: Phase II

Latest Information Update: 09 Jul 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

02 Jul 2025 Status changed from planning to withdrawn prior to enrolment.According to Organon media release, based on the results of Phase 2 ELENA, company plans to discontinue the OG-6219 clinical development program.
22 Jul 2019 New trial record
17 Jul 2019 According to a Sunstone Life Science Ventures media release, Sunstone announced its first investment out of its Life Science Ventures Fund IV into Forendo Pharma to finance this study.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com